Correlation Between Unicycive Therapeutics and Biora Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Biora Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Biora Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Biora Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Biora Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Biora Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Biora Therapeutics.

Diversification Opportunities for Unicycive Therapeutics and Biora Therapeutics

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Unicycive and Biora is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Biora Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biora Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Biora Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biora Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Biora Therapeutics go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Biora Therapeutics

Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 0.4 times more return on investment than Biora Therapeutics. However, Unicycive Therapeutics is 2.52 times less risky than Biora Therapeutics. It trades about 0.37 of its potential returns per unit of risk. Biora Therapeutics is currently generating about -0.4 per unit of risk. If you would invest  53.00  in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of  27.00  from holding Unicycive Therapeutics or generate 50.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Unicycive Therapeutics  vs.  Biora Therapeutics

 Performance 
       Timeline  
Unicycive Therapeutics 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Biora Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biora Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Unicycive Therapeutics and Biora Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Unicycive Therapeutics and Biora Therapeutics

The main advantage of trading using opposite Unicycive Therapeutics and Biora Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Biora Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biora Therapeutics will offset losses from the drop in Biora Therapeutics' long position.
The idea behind Unicycive Therapeutics and Biora Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes